Inozyme Pharma Inc reports results for the quarter ended in March - Earnings Summary

Inozyme Pharma

12/05/2021 14:32

* Inozyme Pharma Inc  INZY.OQ  reported a quarterly adjusted
loss of 47 cents​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 54 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Inozyme Pharma Inc's reported EPS for the quarter was a loss
of 47 cents​.
* The mean earnings estimate of analysts had risen by about 4.4%
in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Inozyme Pharma Inc shares had fallen by 18.4% this quarter and
lost 21.8% so far this year.
* The company reported a quarterly loss of $11.05 million.
* Wall Street's median 12-month price target for Inozyme Pharma
Inc is $37.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 12 at 01:32 p.m. GMT.
​All figures in US dollars